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Introduction
Sepsis is a life-threatening condition characterized by one 
or more organ dysfunctions due to a dysregulated host 
response to infection [1] or, in certain cases, due to direct 
pathogen effects. Sepsis is not only associated with bacte-
rial or fungal infections but also with any other infection 
such as viral disease, protozoal (e.g., malaria), or tropical 
infections. Although the literature suggests that sepsis is 
predominantly a healthcare issue in resource-rich coun-
tries, the global burden of acute infections is highest in 
resource-limited areas [2]. Successful sepsis management 
relies on various components of which early recognition 
is essential. Evidence and recommendations for sepsis 
recognition are mainly based on research performed in 
resource-rich settings [3]. However, resource-rich and 
-limited countries differ in healthcare accessibility [4] 
and infectious disease epidemiology [5–7]. It is there-
fore unreasonable to directly translate evidence between 
these settings.
The Global Intensive Care working group of the Euro-
pean Society of Intensive Care Medicine together with 
the Mahidol-Oxford Research Unit formed an interna-
tional team of physicians to revise existent recommenda-
tions for sepsis management in resource-limited settings 
[8]. In this manuscript, we summarize recommendations 
on sepsis recognition. A detailed description of the 
guideline team, conflicts of interest, methods, rationales, 
and references is given in the Online supplement.
Results and recommendations for sepsis 
recognition in resource‑limited settings
Four clearly defined questions regarding sepsis recogni-
tion in resource-limited settings were formulated using 
the GRADEpro Guideline Development Tool [9]. The 
literature search was performed using the same tech-
niques as described for the Surviving Sepsis Campaign 
guidelines [3]. Specific attention was paid to identify 
publications originating from resource-limited settings. 
The quality of evidence was classified as high (grade  A) 
to very low (grade  D) and recommendations as strong 
(grade  1—‘we recommend’) or weak (grade  2—‘we sug-
gest’) [9]. Factors influencing this classification were the 
level of scientific evidence, certainty about the benefit/
risk ratio, certainty in or similar values, resource implica-
tions, availability and feasibility, affordability, and safety 
for resource-limited settings (Table 1).
With regard to sepsis recognition, we recommend 
defining sepsis in adults as the combination of acute 
infection and the presence of two of the following three 
parameters: (a) respiratory rate ≥22  bpm, (b) systolic 
blood pressure ≤100  mmHg, (c) any acute change in 
mental state; these criteria have not been validated to 
recognize sepsis from non-bacterial infections such as 
malaria, dengue, or other tropical infectious diseases. 
Until data confirm their predictive value in malaria, we 
recommend diagnosing malaria-induced sepsis if malaria 
and one or more of the following signs occur: impaired 
consciousness, prostration, respiratory distress, mul-
tiple convulsions, hypoglycemia, severe malarial anae-
mia, renal impairment, jaundice, malaria-induced shock, 
significant bleeding, hyperparasitemia. Similarly, until 
further data are available, we recommend diagnosing 
dengue-induced sepsis if dengue infection and any of the 
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following symptoms occur: shock, respiratory distress, 
severe bleeding, or any organ dysfunction; we recom-
mend that healthcare workers, irrespective of their pro-
ficiency, be alert to consider sepsis in adults and children 
with acute infection of any etiology. Recognition of sepsis 
in children is based on different severity indicators; these 
are summarized in another set of the expert consensus 
recommendations that will be published separately.
With regard to identification of the underlying type 
of infection, we recommend taking a structured patient 
history and performing a systematic head-to-toe 
physical examination (online supplement Table  3) to 
identify the underlying type of infection; thereby, con-
sideration of local epidemiology of infectious diseases 
is crucial. Depending on their availability/affordability, 
we recommend performing additional diagnostic evalu-
ations such as laboratory testing and/or radiographic or 
ultrasound imaging to identify the source of infection, as 
guided by the history and physical examination.
With regard to identification of the causative microbio-
logical pathogen, we recommend, if available/affordable, 
obtaining microbiological cultures before antimicrobial 
therapy as long as this does not relevantly delay antimi-
crobial therapy. We recommend taking two or more sets 
of blood cultures and/or tissue/body secretions from the 
site of suspected infection. We recommend perform-
ing microscopy and Gram staining of secretions sam-
pled from the suspected source of infection. If available/
affordable, we recommend testing for antibiotic suscep-
tibility of cultured bacteria to guide antibiotic therapy. 
Table 1 Recommendations for sepsis recognition in resource‑limited settings (with grading)
PCR polymerase chain reaction, HIV human immunodeficiency virus
1 Recognition of sepsis Define sepsis as the combination of acute infection and two of the following parameters: 
respiratory rate ≥22 bpm, systolic blood pressure ≤100 mmHg, any acute change in 
mental state (1B); these criteria have not been validated to recognize patients with 
sepsis from non-bacterial infections such as malaria, dengue, or other tropical infectious 
diseases (ungraded); diagnose malaria-induced sepsis if malaria and one or more of the 
following clinical signs occur: impaired consciousness, prostration, respiratory distress, 
multiple convulsions, hypoglycemia, severe malarial anaemia, renal impairment, 
jaundice, malaria-induced shock, significant bleeding, hyperparasitemia (1B); diagnose 
dengue-induced sepsis if dengue infection and any of the following clinical symp-
toms occur: shock, respiratory distress, severe bleeding, or any organ dysfunction (1B); 
healthcare workers, irrespective of their proficiency, be alert to consider sepsis in adults 
and children with acute infection of any etiology (1C); recognition of sepsis in children 
is based on different severity indicators (ungraded)
2 Identification of the underlying type of infection Take a structured patient history and perform a systematic head-to-toe physical examina-
tion to identify the underlying type of infection (1A); recognition of local infectious 
disease epidemiology is crucial (ungraded); depending on their availability, perform 
additional diagnostic evaluations such as laboratory testing and/or radiographic or 
ultrasound imaging to identify the source of infection (1B)
3 Identification of the causative microbiological pathogen If available, obtain microbiological cultures before antimicrobial therapy as long as this 
does not relevantly delay antimicrobial therapy (1A); take two or more sets of blood 
cultures and tissue/body secretions from the site of suspected infection (1A); perform 
microscopy and Gram staining of secretions sampled from the suspected source of 
infection (1B); if available, test for antibiotic susceptibility of cultured bacteria to guide 
antibiotic therapy (1B); if resources to test for antibiotic susceptibility are not routinely 
available, perform intermittent microbiological screening of antimicrobial susceptibil-
ity of selected pathogens to inform empirical antimicrobial strategies (2C); use rapid 
diagnostic tests to diagnose malaria (1A); alternatively, use light microscopy of stained 
blood smears performed by experienced staff (1A); use direct (early disease phase) or 
indirect (intermediate or later disease phase) laboratory methods to diagnose specific 
virus infections such as dengue, influenza, or ebola virus disease (1A); all patients with 
an acute infection who are positive for the human immunodeficiency virus, suffer from 
immunosuppression of other causes (e.g., malnutrition), had previous tuberculosis 
infection and/or close contact with a person suffering from tuberculosis should be 
screened for tuberculosis co-infection (1A); use light emitting diode microscopy of two 
sputum smears or field PCR for the diagnosis of pulmonary tuberculosis (1A); perform 
tuberculosis cultures in HIV-positive patients (1A)
4 Recognition of septic shock Define septic shock as the presence of two or more clinical indicators of systemic tissue 
hypoperfusion independent of the presence of arterial hypotension (1B); if available, 
measure arterial lactate levels (1A); in patients with dengue sepsis, use a change in arte-
rial blood pressure amplitude of ≤20 mmHg to diagnose shock (1C); do not rely solely 
on the use of arterial hypotension to diagnose septic shock, as arterial hypotension 
is typically a preterminal event and associated with an exceedingly high mortality in 
sepsis patients in resource-limited settings (1C)
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If resources to test for antibiotic susceptibility are not 
routinely available, we suggest performing intermittent 
microbiological screening of antimicrobial susceptibility 
of selected pathogens to inform empirical antimicrobial 
strategies. We recommend using rapid diagnostic tests 
to diagnose malaria; alternatively, we recommend light 
microscopy of stained blood smears performed by expe-
rienced staff. We recommend using direct (early disease 
phase) or indirect (intermediate or later disease phase) 
laboratory methods to diagnose specific virus infec-
tions such as dengue, influenza, or ebola virus disease. 
All patients with an acute infection who are positive for 
the human immunodeficiency virus, suffer from immu-
nosuppression of other causes (e.g., malnutrition), had 
previous tuberculosis infection and/or close contact with 
person suffering from tuberculosis should be screened 
for tuberculosis co-infection. We recommend light emit-
ting diode microscopy of two sputum smears for the 
diagnosis of pulmonary tuberculosis. Whenever avail-
able/affordable, we recommend using polymerase chain 
reaction (PCR) tests to diagnose tuberculosis or perform-
ing tuberculosis cultures in HIV-positive patients.
With regard to recognition of septic shock, we recom-
mend defining septic shock as the presence of two or 
more clinical indicators of systemic tissue hypoperfusion 
independent of the presence of arterial hypotension. If 
available/affordable, we recommend measuring arterial 
lactate levels in patients with sepsis. In dengue sepsis, we 
recommend using a reduction in the arterial blood pres-
sure amplitude ≤20  mmHg to diagnose shock. We rec-
ommend against relying solely on arterial hypotension as 
a diagnostic criterion for the diagnosis of septic shock, as 
arterial hypotension is typically a preterminal event and 
associated with an exceedingly high mortality in sepsis 
patients in resource-limited settings.
Conclusion
Sepsis is not only associated with bacterial or fun-
gal infections but also with any other infection such as 
viral disease, protozoal (e.g., malaria), or tropical infec-
tions. We provided a set of simple, readily available, and 
affordable recommendations on how to recognize sep-
sis, identify the underlying type of infection, identify the 
causative microbiological pathogen, and recognize sep-
tic shock in resource-limited settings. As most evidence 
originates from resource-rich settings, there is an urgent 
need for related research in resource-limited settings.
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